hsa‑miR‑15a‑5p inhibits colon cell carcinoma via targeting CCND1

Li,Zhipeng; Zhu,Zeyu; Wang,Yanjun; Wang,Ying; Li,Weibing; Wang,Zhigang; Zhou,Xinyuan; Bao,Yuhua

doi:10.3892/mmr.2021.12375

hsa‑miR‑15a‑5p inhibits colon cell carcinoma via targeting CCND1

Authors:
- Zhipeng Li
- Zeyu Zhu
- Yanjun Wang
- Ying Wang
- Weibing Li
- Zhigang Wang
- Xinyuan Zhou
- Yuhua Bao
View Affiliations

Affiliations: Department of Integrated Traditional Chinese and Western Medicine, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China, Department of Orthopedics, Huaian Hospital, Huaian, Jiangsu 223200, P.R. China, Department of Women's Preventive Health, Huishan No. 2 People's Hospital, Wuxi, Jiangsu 214400, P.R. China, Department of Radiotherapy, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China, Department of Hospital Quality Management, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China, Department of Gastroenterology, Wuxi Hospital of TCM, Affiliated to Nanjing University of Chinese Medicine, Wuxi, Jiangsu 214000, P.R. China
Published online on: August 16, 2021 https://doi.org/10.3892/mmr.2021.12375
Article Number: 735
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colon carcinoma is one of the most common cancers worldwide. Epidemiological studies have revealed that colon cancer is the third leading cause of cancer‑related deaths, which is due to the increased incidence and mortality rates. However, the treatment strategies for colon cancer remain unsatisfactory for patients, especially for those with advanced or recurrent colon cancer. Dysregulated microRNAs (miRNAs) are considered to influence tumor development and metastasis. However, the molecular mechanism through which miRNAs affect cancer progression is not yet completely understood. The aim of the present study was to investigate the expression levels of has‑miR‑15a‑5p and its molecular mechanism in colon cell carcinoma. In the present study, the expression levels of hsa‑miR‑15a‑5p were found to be decreased in colon tumor tissues and cancer cell lines. Hsa‑miR‑15a‑5p overexpression inhibited colon cell proliferation and migration. Mechanistically, the G1/S‑specific cyclin‑D1 (CCND1) gene was predicted as a target of hsa‑miR‑15a‑5p, as evidenced by bioinformatics and dual‑luciferase reporter assay analyses. CCND1 overexpression significantly increased the progression of colon cancer. Furthermore, CCND1 was demonstrated to mediate the effects of hsa‑miR‑15a‑5p on colon cancer cells. The present study demonstrated that hsa‑miR‑15a‑5p alleviated the proliferation, migration and invasion of colon cancer by targeting the CCND1 gene, which represents a potential molecular target for the diagnosis and treatment of colon cancer.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Itatani Y, Kawada K, Fujishita T, Kakizaki F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa S, et al: Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1⁺ myeloid cells and facilitate liver metastasis. Gastroenterology. 145:1064–1075.e11. 2013. View Article : Google Scholar : PubMed/NCBI
3	Aghakhani A, Hamkar R, Ramezani A, Bidari-Zerehpoosh F, Sabeti S, Ghavami N, Banifazl M, Rashidi N and Eslamifar A: Lack of human papillomavirus DNA in colon adenocarcinama and adenoma. J Cancer Res Ther. 10:531–534. 2014.PubMed/NCBI
4	Zhang Y, Lin C, Liao G, Liu S, Ding J, Tang F, Wang Z, Liang X, Li B, Wei Y, et al: MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2. Oncotarget. 6:32586–32601. 2015. View Article : Google Scholar : PubMed/NCBI
5	Chen L, Wang J, Fu L, Zhang B, Zhang H and Ye B: Prognostic significance of metastasis associated in colon cancer 1 (MACC1) expression in patients with gallbladder cancer. J Cancer Res Ther. 10:1052–1056. 2014. View Article : Google Scholar : PubMed/NCBI
6	Manjelievskaia J, Brown D, McGlynn KA, Anderson W, Shriver CD and Zhu K: Chemotherapy use and survival among young and middle-aged patients with colon cancer. JAMA Surg. 152:452–459. 2017. View Article : Google Scholar : PubMed/NCBI
7	Nicoloso MS, Spizzo R, Shimizu M, Rossi S and Calin GA: MicroRNAs-the micro steering wheel of tumour metastases. Nature reviews. Cancer. 9:293–302. 2009.PubMed/NCBI
8	Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
9	Schwarzenbach H: Clinical relevance of circulating, cell-free and exosomal microRNAs in plasma and serum of breast cancer patients. Oncol Res Treat. 40:423–429. 2017. View Article : Google Scholar : PubMed/NCBI
10	Alvarez-Díaz S, Valle N, Ferrer-Mayorga G, Lombardía L, Herrera M, Domínguez O, Segura MF, Bonilla F, Hernando E and Muñoz A: MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum Mol Genet. 21:2157–2165. 2012. View Article : Google Scholar : PubMed/NCBI
11	Cai SD, Chen JS, Xi ZW, Zhang LJ, Niu ML and Gao ZY: MicroRNA-144 inhibits migration and proliferation in rectal cancer by downregulating ROCK-1. Mol Med Rep. 12:7396–7402. 2015. View Article : Google Scholar : PubMed/NCBI
12	Cottonham CL, Kaneko S and Xu L: miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem. 285:35293–302. 2010. View Article : Google Scholar : PubMed/NCBI
13	Yi H, Geng L, Black A, Talmon G, Berim L and Wang J: The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis. Oncogene. 36:3477–3489. 2017. View Article : Google Scholar : PubMed/NCBI
14	Li X, Li Z, Zhu Y, Li Z, Yao L, Zhang L, Yuan L, Shang Y, Liu J and Li C: miR-524-5p inhibits angiogenesis through targeting WNK1 in colon cancer cells. Am J Physiol Gastrointest Liver Physiol. 318:827–839. 2020. View Article : Google Scholar : PubMed/NCBI
15	Mullany LE, Herrick JS, Sakoda LC, Samowitz W, Stevens JR, Wolff RK and Slattery ML: miRNA involvement in cell cycle regulation in colorectal cancer cases. Genes Cancer. 9:53–65. 2018. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Chang L, Guo R, Yuan Z, Shi H and Zhang D: LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer. Cell Physiol Biochem. 49:1289–1303. 2018. View Article : Google Scholar : PubMed/NCBI
18	Douaiher J, Ravipati A, Grams B, Chowdhury S, Alatise O and Are C: Colorectal cancer-global burden, trends, and geographical variations. J Surg Oncol. 115:619–630. 2017. View Article : Google Scholar : PubMed/NCBI
19	Pan Y, Zhang J, Fu H and Shen L: miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process. Onco Targets Ther. 9:6247–6255. 2016. View Article : Google Scholar : PubMed/NCBI
20	Chen Q, Xia HW, Ge XJ, Zhang YC, Tang QL and Bi F: Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases. Asian Pac J Cancer Prev. 14:7421–7426. 2013. View Article : Google Scholar : PubMed/NCBI
21	Ritchie W, Rasko JE and Flamant S: MicroRNA target prediction and validation. Adv Exp Med Biolgy. 774:39–53. 2013. View Article : Google Scholar : PubMed/NCBI
22	Aqeilan RI, Calin GA and Croce CM: miR-15a and miR-16-1 in cancer: Discovery, function and future perspectives. Cell Death Differ. 17:215–220. 2010. View Article : Google Scholar : PubMed/NCBI
23	Orhan C, Bulut P, Dalay N, Ersen E and Buyru N: Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer. Mol Biol Rep. 46:5251–5256. 2019. View Article : Google Scholar : PubMed/NCBI
24	Chen G, Hu M, Qu X, Wang K and Qu Y: MicroRNA-584 directly targets CCND1 and inhibits cell proliferation and invasion in pancreatic cancer. Mol Med Rep. 19:719–726. 2019.PubMed/NCBI
25	Dai J, Wei RJ, Li R, Feng JB, Yu YL and Liu PS: A study of CCND1 with epithelial ovarian cancer cell proliferation and apoptosis. Eur Rev Med Pharmacol Sci. 20:4230–4235. 2016.PubMed/NCBI
26	Hao CY, Zhao S, Zhang LL and Liu D: SNHG16 promotes the progression of osteoarthritis through activating microRNA-93-5p/CCND1 axis. Eur Rev Med Pharmacol Sci. 23:9222–9229. 2019.PubMed/NCBI
27	Nie M, Wang Y, Yu Z, Li X, Deng Y, Wang Y, Yang D, Li Q, Zeng X, Ju J, et al: AURKB promotes gastric cancer progression via activation of CCND1 expression. Aging (Albany NY). 12:1304–1321. 2020. View Article : Google Scholar : PubMed/NCBI